A- A A+

Two world first studies of depot buprenorphine completed

Two world first studies of depot buprenorphine have recently been completed. Both studies are great achievements at the forefront of international research efforts in this field and have salience as part of the response to COVID-19. (NDARC - National Drug and Alcohol Research Centre, Australien, April 2020)

https://ndarc.med.unsw.edu.au/two-world-first-studies-depot-buprenorphine-completed